News & Updates
- Dunad Therapeutics Announces Appointment of Chief Business OfficerFormer uniQure and Nocion Therapeutics Executive Jonathan Garen joins Dunad Therapeutics Leadership Team CAMBRIDGE, England – Aug. 8, 2023 Dunad… Read more: Dunad Therapeutics Announces Appointment of Chief Business Officer
- Dunad Therapeutics Appoints Michael Bonney as Chair of Board of DirectorsBonney brings over 30 years of life sciences industry leadership experience as company advances its covalent chemistry platform for targeted… Read more: <strong>Dunad Therapeutics Appoints Michael Bonney as Chair of Board of Directors</strong>
- Interview with Dunad CEO Pearl Huang in Nature Reviews Drug DiscoveryDunad CEO Pearl Huang was recently featured in a Q&A interview with Asher Mullard for Nature Reviews Drug Discovery. Check… Read more: Interview with Dunad CEO Pearl Huang in Nature Reviews Drug Discovery
- Dunad Therapeutics Announces Appointment of Chief R&D OfficerFormer Novartis and AstraZeneca industry veteran Ruben Tommasi joins Dunad Therapeutics leadership team CAMBRIDGE, England–(BUSINESS WIRE)–Dunad Therapeutics, a biopharmaceutical company… Read more: Dunad Therapeutics Announces Appointment of Chief R&D Officer
- Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive OfficerDr. Huang brings more than 30 years of biopharma experience, most recently as Chief Executive Officer and President of Flagship… Read more: Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer
- Dunad Therapeutics enters Strategic Collaboration with NovartisDunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies Novartis to leverage Dunad’s proprietary… Read more: Dunad Therapeutics enters Strategic Collaboration with Novartis
- Dunad Therapeutics Emerges To Develop Next-generation Small Molecule TherapeuticsDunad Therapeutics Emerges To Develop Next-generation Small Molecule Therapeutics Based On First Tuneable Targeted Protein Degradation Technology CAMBRIDGE, England, March… Read more: Dunad Therapeutics Emerges To Develop Next-generation Small Molecule Therapeutics